Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan

References

• MurrayCJLopezADAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet19973499064149815049167458
   PubMed Web of Science ®Google Scholar
• LopezADShibuyaKRaoCChronic obstructive pulmonary disease: current burden and future projectionsEur Respir J200627239741216452599
   PubMed Web of Science ®Google Scholar
• TakahashiTIchinoseMInoueHShiratoKHattoriTTakishimaTUnderdiagnosis and undertreatment of COPD in primary care settingsRespirology20038450450814629656
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
   PubMed Web of Science ®Google Scholar
• OmoriHNonamiYMiharaSMarubayashiTMorimotoYAizawaHPrevalence of airflow limitation on medical check-up in Japanese subjectsJ UOEH200729320921917900001
   PubMedGoogle Scholar
• FinkelsteinJChaEScharfSMChronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidityInt J Chron Obstruct Pulmon Dis2009433734919802349
   PubMedGoogle Scholar
• SinDDManSFPChronic obstructive pulmonary disease: a novel risk factor for cardiovascular diseaseCan J Physiol Pharmacol200583181315759045
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension, and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• HawkinsNMHuangZPieperKSChronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Eur J Heart Fail200911329229819176539
   PubMed Web of Science ®Google Scholar
• SorianoJBRigoFGuerreroDHigh prevalence of undiagnosed airflow limitation in patients with cardiovascular diseaseChest2010137233334019783666
   PubMed Web of Science ®Google Scholar
• WadaHNakanoYNagaoTDetection and prevalence of chronic obstructive pulmonary disease in a cardiovascular clinic: evaluation using a hand held FEV1/FEV6 meter and questionnaireRespirology20101581252115820920134
   PubMed Web of Science ®Google Scholar
• YamasakiAHashimotoKHasegawaYCOPD is frequent in conditions of comorbidity in patients treated with various diseases in a university hospitalInt J Chron Obstruct Pulmon Dis2010535135521037959
   PubMedGoogle Scholar
• AgustíAGNogueraASauledaJSalaEPonsJBusquetsXSystemic effects of chronic obstructive pulmonary diseaseEur Respir J200321234736012608452
   PubMed Web of Science ®Google Scholar
• CurkendallSMLanesSde LuiseCChronic obstructive pulmonary disease severity and cardiovascular outcomesEur J Epidemiol2006211180381317106760
   PubMed Web of Science ®Google Scholar
• DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
   PubMed Web of Science ®Google Scholar
• DalalAAShahMLunacsekOHananiaNAClinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular diseaseRespir Med2011105101516152221684731
   PubMed Web of Science ®Google Scholar
• MüllerovaHAgustiAErqouSMapelDWCardiovascular comorbidity in COPD: systematic literature reviewChest201314441163117823722528
   PubMed Web of Science ®Google Scholar
• JonesPWHardingGBerryPWiklundIChenWHLeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• Japanese Respiratory SocietyGuidelines for the Diagnosis and Treatment of COPD3rd edTokyoJapanese Respiratory Society2009
   Google Scholar
• VandevoordeJVerbanckSSchuermansDKartounianJVinckenWObstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6Eur Respir J200627237838316452596
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA1994272149715057966841
   PubMed Web of Science ®Google Scholar
• BursiFVassalloRWestonSAKillianJMRogerVLChronic obstructive pulmonary disease after myocardial infarction in the communityAm Heart J201016019510120598978
   PubMed Web of Science ®Google Scholar
• SalisburyACReidKJSpertusJAImpact of chronic obstructive pulmonary disease on post-myocardial infarction outcomesAm J Cardiol200799563664117317363
   PubMed Web of Science ®Google Scholar
• GanSCBeaverSKHouckPMMacLehoseRFLawsonHWChanLTreatment of acute myocardial infarction and 30-day mortality among women and menN Engl J Med2000343181510882763
   PubMed Web of Science ®Google Scholar
• NakanoYNagaiAMishimaMYoshimotoDHaganGInvestigation of COPD management in primary care in Japan using handheld spirometerKokyu201231273281 Japanese
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD) [cited: September 19, 2013]. Available from: http://www.goldcopd.org/Accessed September 19, 2013
   Google Scholar
• ManninoDMDohertyDESonia BuistAGlobal Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) studyRespir Med2006100111512215893923
   PubMed Web of Science ®Google Scholar
• UlrikCSLøkkeADahlRTOP study groupEarly detection of COPD in general practiceInt J Chron Obstruct Pulmon Dis2011612312721407825
   PubMed Web of Science ®Google Scholar
• MiravitllesMSorianoJBGarcía-RíoFPrevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activitiesThorax2009641086386819553233
   PubMed Web of Science ®Google Scholar
• NishimuraKMitsumaSKobayashiACOPD and disease-specific health status in a working populationRespir Res2012141616623725096
   PubMed Web of Science ®Google Scholar